Clinical Trials Directory

Trials / Completed

CompletedNCT03027232

Control of Leukocyte Function

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The protocol is to draw peripheral blood from healthy volunteers for in vitro studies. The aims of these in vitro studies are to determine the cellular and intracellular mechanisms by which hypertonic saline and ATP release regulate neutrophil and lymphocyte functions.

Detailed description

The proper regulation of leukocyte function is critical for immune defense and to prevent autoimmune diseases. Many aspects of immune cell regulation are unknown. A better understanding could lead to novel therapeutic approaches to improve immune function in patients suffering from various diseases. The investigators have found that hypertonic conditions regulate leukocyte functions through feedback mechanisms involving ATP release and purinergic receptors. The purpose of the proposed protocol is to obtain access to peripheral blood from healthy volunteers to study these complex regulatory mechanisms in more detail.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention (drugs) will be given. Purpose: collecting blood for in vitro studiesNo drugs or interventions are given. Single purpose is to draw blood from healthy subjects to study immune cell biology in vitro. No records about subjects to be kept.

Timeline

Start date
2007-01-01
Primary completion
2017-12-15
Completion
2017-12-15
First posted
2017-01-23
Last updated
2018-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03027232. Inclusion in this directory is not an endorsement.